3rd Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Period 3rd Quarter 2008 Filed Oct 15, 2008 Signed by Jerome L. Steffl, Vice President, Government Affairs

Official filing
Firm
PRIME THERAPEUTICS
Client
PRIME THERAPEUTICS
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Generic Pharmaceuticals, Healthcare Reform, Health Information Technology, Health Information Privacy, Antitrust, Comaprative Effectiveness Researc, Medicare Part D HR 971, H.R. 6898, H.R. 6357, HR 6331

LobbyistCovered position, as disclosed
JERRY STEFFL New —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 6357 (110th), H.R. 6898 (110th), H.R. 971 (110th), H.R. 6331 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.